1. Home
  2. PMT vs SYRE Comparison

PMT vs SYRE Comparison

Compare PMT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMT
  • SYRE
  • Stock Information
  • Founded
  • PMT 2009
  • SYRE 2013
  • Country
  • PMT United States
  • SYRE United States
  • Employees
  • PMT N/A
  • SYRE N/A
  • Industry
  • PMT Real Estate Investment Trusts
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMT Real Estate
  • SYRE Health Care
  • Exchange
  • PMT Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • PMT 1.2B
  • SYRE 1.2B
  • IPO Year
  • PMT 2009
  • SYRE 2016
  • Fundamental
  • Price
  • PMT $14.50
  • SYRE $18.33
  • Analyst Decision
  • PMT Buy
  • SYRE Strong Buy
  • Analyst Count
  • PMT 6
  • SYRE 8
  • Target Price
  • PMT $15.25
  • SYRE $51.50
  • AVG Volume (30 Days)
  • PMT 689.6K
  • SYRE 643.4K
  • Earning Date
  • PMT 04-23-2025
  • SYRE 05-08-2025
  • Dividend Yield
  • PMT 11.22%
  • SYRE N/A
  • EPS Growth
  • PMT N/A
  • SYRE N/A
  • EPS
  • PMT 1.37
  • SYRE N/A
  • Revenue
  • PMT $504,603,000.00
  • SYRE N/A
  • Revenue This Year
  • PMT N/A
  • SYRE N/A
  • Revenue Next Year
  • PMT $1.57
  • SYRE N/A
  • P/E Ratio
  • PMT $10.43
  • SYRE N/A
  • Revenue Growth
  • PMT N/A
  • SYRE N/A
  • 52 Week Low
  • PMT $11.77
  • SYRE $17.24
  • 52 Week High
  • PMT $15.22
  • SYRE $47.97
  • Technical
  • Relative Strength Index (RSI)
  • PMT 54.80
  • SYRE 38.91
  • Support Level
  • PMT $14.14
  • SYRE $17.50
  • Resistance Level
  • PMT $14.93
  • SYRE $21.03
  • Average True Range (ATR)
  • PMT 0.29
  • SYRE 1.68
  • MACD
  • PMT -0.06
  • SYRE -0.07
  • Stochastic Oscillator
  • PMT 23.86
  • SYRE 22.89

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: